Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma, Follicular × selpercatinib × 1 year × Clear all

Sponsor

Conditions

Thyroid Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Carcinoma, Medullary 5 Thyroid Cancer, Papillary 3 Sarcoma 3 Lung Neoplasms 3 Central Nervous System Neoplasms 3 Wilms Tumor 2 Thyroid Diseases 2 Thoracic Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Neoplasms by Site 2 Neoplasms 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Lung Diseases 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Head and Neck Neoplasms 2 Glioma 2 Ependymoma 2 Endocrine System Diseases 2 Endocrine Gland Neoplasms 2

Interventions

X-Rays 3 Magnetic Resonance Spectroscopy 3 Specimen Handling 2 tremelimumab 1 trametinib 1 spartalizumab 1 pembrolizumab 1 lenvatinib 1 gallium Ga 68 dotatate 1 durvalumab 1 dabrafenib 1 cobimetinib 1 cabozantinib 1 Vemurafenib 1 Thyrotropin Alfa 1 Sunitinib 1 Photons 1 Pharmacogenomic Testing 1 Phantoms, Imaging 1 Iodine-131 1 Iodine-123 1 High-Energy Shock Waves 1 Glycoprotein Hormones, alpha Subunit 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡